After Robert W. Baird and H.C. Wainwright gave Albireo Pharma (NASDAQ: ALBO) a Buy rating last month, the company received
Freshworks (FRSH – Research Report) received a Buy rating and a $50.00 price target from Oppenheimer analyst Brian Schwartz today.
Wells Fargo analyst Ike Boruchow maintained a Buy rating on Levi Strauss & Co (LEVI – Research Report) on October
In a report issued on October 14, Daina Graybosch from Leerink Partners maintained a Buy rating on Silverback Therapeutics (SBTX
William Blair analyst Matt Phipps reiterated a Buy rating on Atara Biotherapeutics (ATRA – Research Report) on October 13. The
Analysts fell to the sidelines weighing in on and Hess Midstream Partners (HESM – Research Report) with neutral ratings, indicating
Analysts are pulling back from the Conglomerates sector as 1 experts expressed today bearish sentiments on and Deutsche Lufthansa AG